MedTrace Logo

A Study to Determine Whether Urinary PGE-M Levels Correlate With Ulcerative Colitis Disease

NCT00409396 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 35

Last updated 2015-06-09

No results posted yet for this study

Summary

The purpose of this study is to determine whether urinary PGE-M levels correlate with Ulcerative Colitis Disease activity and to compare how well urinary PGEm correlates with other noninvasive biomarkers of disease activity such as CRP and fecal calprotectin.

Conditions

Interventions

PROCEDURE

Urinary PGEm level

Level of PGEm in urine compared to CRP and fecal calprotectin levels in patients with ulcerative colitis.

PROCEDURE

fecal calprotectin

Level of fecal calprotectin in comparison to urinary PGEm and serum CRP levels.

Sponsors & Collaborators

  • Procter and Gamble

    collaborator INDUSTRY

  • Vanderbilt University

    lead OTHER

Principal Investigators

  • David A. Schwartz, MD · Vanderbilt University Medical Center

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-11-30
Primary Completion
2007-11-30
Completion
2007-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00409396 on ClinicalTrials.gov